TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +0.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Elicio Therapeutics Inc. (ELTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 31 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ELTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
31 27 24 16 38 28 28 30 28 26 23 31
20 16 14 6.7 31 21 21 23 21 19 16 25
15 13 12 3.8 26 18 18 22 21 19 15 23
15 13 12 3.8 26 18 18 22 21 19 15 23
0.1 – – 0.1 0.0 – – – – – – –
-0.1 – – – – – – – – – – –
18 16 20 17 57 39 19 28 24 24 24 23
11 9.8 6.0 7.6 9.0 12 11 9.9 6.5 8.1 7.2 9.2
0.9 0.9 0.9 0.9 0.9 0.9 0.9 1.0 1.0 1.0 1.0 1.1
4.4 4.4 1.1 1.1 2.0 1.0 4.0 3.9 0.3 0.7 0.3 0.8
– – – – 20 20 – 9.3 9.7 9.4 9.5 9.5
13 11 4.9 -1.7 -19 -11 8.9 1.8 3.8 1.6 -1.4 7.9
-133 -142 -154 -161 -180 -194 -205 -216 -226 -234 -245 -254
4.1 9.6 10 11 14 12 13 16 17 15 18 19

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?